Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Henan Province, 450052, China; Henan Engineering Research Center of Clinical Mass Spectrometry for Precision Medicine, Henan Province, 450052, China.
Department of Pharmacy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118732. doi: 10.1016/j.jep.2024.118732. Epub 2024 Aug 23.
XBJ injection is approved by the China Food and Drug Administration for the adjunctive treatment of sepsis, and it is derived from the traditional Chinese medicine (TCM) prescription XuefuZhuyu Decoction. It consists of five Chinese herbal extracts: Carthamus tinctorius, Paeonia lactiflora, Salvia miltiorrhiza, Conioselinum anthriscoides 'Chuanxiong' and Angelica sinensis.
The purpose of this study was to explore the relationship between ferroptosis and acute septic lung injury, and to evaluate the improvement effect of XBJ injection on acute lung injury in sepsis.
Acute lung injury was induced in rats by cecum ligation and puncture, and these rats were treated with XBJ injection. Oxidative stress and inflammation levels were assessed in serum and lung tissue, and tissue samples were collected for histological and protein analyses. To illustrate the mechanism of the improvement effect of XBJ on acute lung injury in sepsis, serum lipidomics was carried out to investigate whether XBJ prevents oxidative stress-induced lipid metabolism disorders. Furthermore, protein expression of ferroptosis-related genes was also examined.
XBJ was shown to be effective in alleviating sepsis-induced ALI. XBJ also improves sepsis-induced acute lung injury by reducing lipid peroxidation and inflammation and modulating ferroptosis pathways. Specifically, compared with the sham group, XBJ downregulated the levels of Fe, MDA and GSSG, and reversed the decrease in the levels of GSH and GSH/GSSH in lung tissue. Metabolic pathways such as glycerophospholipid metabolism, phospholipid metabolism, and lipid metabolism associated with ferroptosis were obtained by lipidomic analysis of differential lipid metabolite enrichment, suggesting that ferroptosis occurs in septic rats, and that XBJ inhibits ferroptosis and thereby improves sepsis-induced ALI. Furthermore, XBJ optimises iron metabolism and lipid oxide metabolism by regulating the expression of a series of proteins that are closely related to ferroptosis, such as GPX4, ACSL4, x-CT, and FTH1.
Our findings, initially, indicated that XBJ ameliorates sepsis-induced ALI by reducing oxidative stress and ferroptosis, revealing a previously unrecognised mechanism by which XBJ ameliorates sepsis-induced ALI.
XBJ 注射液已获得中国食品药品监督管理局批准,可作为脓毒症的辅助治疗药物,它源自中药(TCM)方剂血府逐瘀汤。它由五种中药提取物组成:红花、白芍、丹参、川芎和当归。
本研究旨在探讨铁死亡与急性脓毒症肺损伤的关系,并评估 XBJ 注射液对脓毒症急性肺损伤的改善作用。
通过盲肠结扎和穿孔术诱导大鼠急性肺损伤,并用 XBJ 注射液进行治疗。检测血清和肺组织中的氧化应激和炎症水平,并采集组织样本进行组织学和蛋白质分析。为了阐明 XBJ 对脓毒症急性肺损伤的改善作用机制,进行了血清脂质组学研究,以探讨 XBJ 是否可以预防氧化应激引起的脂质代谢紊乱。此外,还检测了铁死亡相关基因的蛋白表达。
XBJ 可有效缓解脓毒症引起的 ALI。XBJ 通过减少脂质过氧化和炎症以及调节铁死亡途径来改善脓毒症引起的急性肺损伤。具体而言,与假手术组相比,XBJ 下调了肺组织中 Fe、MDA 和 GSSG 的水平,并逆转了 GSH 和 GSH/GSSH 水平的降低。通过对差异脂质代谢物富集的脂质组学分析,获得了甘油磷脂代谢、磷脂代谢和与铁死亡相关的脂质代谢等代谢途径,提示脓毒症大鼠发生铁死亡,XBJ 抑制铁死亡,从而改善脓毒症引起的 ALI。此外,XBJ 通过调节一系列与铁死亡密切相关的蛋白的表达,优化铁代谢和脂质氧化物代谢,如 GPX4、ACSL4、x-CT 和 FTH1。
我们的研究结果初步表明,XBJ 通过减轻氧化应激和铁死亡来改善脓毒症引起的 ALI,揭示了 XBJ 改善脓毒症引起的 ALI 的一种新的机制。